TITLE

Adjunctive treatment with eplerenone reduced morbidity and mortality in acute myocardial infarction

AUTHOR(S)
Prabhakar, Manu; Massel, David
PUB. DATE
September 2003
SOURCE
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p32
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that analyzed the effectiveness of adjunctive treatment with eplerenone in reducing morbidity and mortality in acute myocardial infarction. Design of the study; Intervention; Outcome measures; Results; Commentary.
ACCESSION #
10987115

 

Related Articles

  • Medication Adherence After Myocardial Infarction: A Long Way Left To Go. Choudhry, Niteesh K.; Winkelmayer, Wolfgang C. // JGIM: Journal of General Internal Medicine;Feb2008, Vol. 23 Issue 2, p216 

    The author reflects on the developments surrounding the medication for the treatment and prevention of myocardial infarction. The medications of coronary heart disease have been subject to various evaluation in trials. Several drugs, which are taken in combination, have been estimated to reduce...

  • Expanded cardiac rehabilitation reduces cardiac events over five years. Redfern, Julie // Journal of Physiotherapy (Australian Physiotherapy Association);2011, Vol. 57 Issue 1, p57 

    The article provides information concerning long-term effects of an expanded cardiac rehabilitation program in patients who have undergone heart surgery in Sweden. It explains the effectiveness of the program which is aimed on reducing mortality rates, myocardial infarctions, and hospital...

  • Cardiovascular highlights from non-cardiology journals. O'Flaherty, Martin; Huffman, Mark D.; Capewell, Simon // Heart;Sep2015, Vol. 101 Issue 17, p1433 

    The article focuses on a study on decreasing mortality rates of acute myocardial infarction (AMI) and coronary heart disease (CHD). Topics discussed include a decrease in mortality rates shown by multinational monitoring of trends and determinants in cardiovascular disease (MONICA) project...

  • Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis. Maggioni, Aldo A.; Maseri, Attilio; Fresco, Claudio; Franzosi, Maria G.; Mauri, Francesco; Santoro, Eugenio; Tognoni, Gianni // New England Journal of Medicine;11/11/93, Vol. 329 Issue 20, p1442 

    Background: The overall rate of mortality due to ischemic heart disease is known to increase progressively with age. We evaluated the relation between the mortality rate and age in patients with first myocardial infarctions treated with thrombolytic therapy. Methods: We studied 9720 patients...

  • Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. O'Donoghue, Michelle; Boden, William E.; Braunwald, Eugene; Cannon, Christopher P.; Clayton, Tim C.; de Winter, Robbert J.; Fox, Keith A. A.; Lagerqvist, Bo; McCullough, Peter A.; Murphy, Sabina A.; Spacek, Rudolf; Swahn, Eva; Wallentin, Lars; Windhausen, Fons; Sabatine, Marc S. // JAMA: Journal of the American Medical Association;7/2/2008, Vol. 300 Issue 1, p71 

    The article presents a meta-analysis of randomized trials comparing the effects and outcomes of an invasive versus a conservative strategy in the treatment of male and female patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). The criteria for data source searching, study...

  • NZ, British, Australian statin guidelines best bet.  // PharmacoEconomics & Outcomes News;6/17/2006, Issue 505, p1 

    The article discusses research being done on the effectiveness and efficiency of different guidelines on statin treatment for preventing mortality from coronary heart disease (CHD). It references a study by D. G. Manuel and colleagues in the June 1, 2006 online issue of the "British Medical...

  • Lack of Benefit From Nitric Oxide Synthase Inhibition in Patients With Cardiogenic Shock. Ndrepepa, Gjin; Schömig, Albert; Kastrati, Adnan // JAMA: Journal of the American Medical Association;4/18/2007, Vol. 297 Issue 15, p1711 

    The article presents an editorial that discusses a lack of benefit associated with the inhibition of nitric oxide synthase in patients with cardiogenic shock complicating acute myocardial infarction (MI). The results of a randomized controlled study, called the Tilarginine Acetate Injection in a...

  • Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing. Kempf, Tibor; Zarbock, Alexander; Vestweber, Dietmar; Wollert, Kai // Journal of Molecular Medicine;Apr2012, Vol. 90 Issue 4, p361 

    The wound healing response after myocardial infarction (MI) involves a cascade of molecular and cellular events that lead to a replacement of the necrotic area with a collagen-rich scar. Clearance of necrotic debris by neutrophils, monocytes, and macrophages is a critical component of infarct...

  • Efficacy of Eplerenone for Treatment of Heart Failure. Zepf, Bill // American Family Physician;12/1/2003, Vol. 68 Issue 11, p2256 

    Presents an abstract of the study "Eplerenone, a Selective Aldosterone Blocker, in Patients With Left Ventricular Dysfunction After Myocardial Infarction," by B. Pitt et al., from the April 3, 2003 issue of the "New England Journal of Medicine."

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics